Patriot Investment Management Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $540K | Buy |
6,512
+387
| +6% | +$32.1K | 0.04% | 151 |
|
2025
Q1 | $497K | Buy |
6,125
+62
| +1% | +$5.03K | 0.04% | 152 |
|
2024
Q4 | $546K | Sell |
6,063
-375
| -6% | -$33.8K | 0.04% | 147 |
|
2024
Q3 | $636K | Hold |
6,438
| – | – | 0.05% | 141 |
|
2024
Q2 | $597K | Sell |
6,438
-375
| -6% | -$34.8K | 0.05% | 146 |
|
2024
Q1 | $646K | Sell |
6,813
-33
| -0.5% | -$3.13K | 0.05% | 140 |
|
2023
Q4 | $611K | Buy |
6,846
+600
| +10% | +$53.6K | 0.05% | 143 |
|
2023
Q3 | $456K | Sell |
6,246
-764
| -11% | -$55.8K | 0.04% | 159 |
|
2023
Q2 | $583K | Buy |
7,010
+214
| +3% | +$17.8K | 0.05% | 153 |
|
2023
Q1 | $518K | Buy |
6,796
+5
| +0.1% | +$381 | 0.05% | 163 |
|
2022
Q4 | $607K | Sell |
6,791
-55
| -0.8% | -$4.92K | 0.05% | 151 |
|
2022
Q3 | $543K | Sell |
6,846
-200
| -3% | -$15.9K | 0.06% | 152 |
|
2022
Q2 | $523K | Buy |
7,046
+1,111
| +19% | +$82.5K | 0.05% | 158 |
|
2022
Q1 | $533K | Buy |
5,935
+415
| +8% | +$37.3K | 0.05% | 173 |
|
2021
Q4 | $618K | Buy |
5,520
+348
| +7% | +$39K | 0.05% | 158 |
|
2021
Q3 | $650K | Buy |
5,172
+95
| +2% | +$11.9K | 0.06% | 149 |
|
2021
Q2 | $687K | Buy |
5,077
+23
| +0.5% | +$3.11K | 0.06% | 143 |
|
2021
Q1 | $685K | Buy |
5,054
+440
| +10% | +$59.6K | 0.07% | 138 |
|
2020
Q4 | $649K | Sell |
4,614
-488
| -10% | -$68.6K | 0.1% | 100 |
|
2020
Q3 | $568K | Hold |
5,102
| – | – | 0.07% | 141 |
|
2020
Q2 | $571K | Buy |
5,102
+434
| +9% | +$48.6K | 0.07% | 135 |
|
2020
Q1 | $361K | Buy |
4,668
+1,301
| +39% | +$101K | 0.05% | 154 |
|
2019
Q4 | $320K | Hold |
3,367
| – | – | 0.04% | 182 |
|
2019
Q3 | $256K | Sell |
3,367
-737
| -18% | -$56K | 0.04% | 192 |
|
2019
Q2 | $359K | Buy |
4,104
+608
| +17% | +$53.2K | 0.05% | 167 |
|
2019
Q1 | $316K | Buy |
+3,496
| New | +$316K | 0.05% | 176 |
|